DK163238C - 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser - Google Patents

3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser

Info

Publication number
DK163238C
DK163238C DK165684A DK165684A DK163238C DK 163238 C DK163238 C DK 163238C DK 165684 A DK165684 A DK 165684A DK 165684 A DK165684 A DK 165684A DK 163238 C DK163238 C DK 163238C
Authority
DK
Denmark
Prior art keywords
tetrazol
compounds
quinolinon
preparing
procedure
Prior art date
Application number
DK165684A
Other languages
Danish (da)
English (en)
Other versions
DK163238B (da
DK165684D0 (da
DK165684A (da
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK165684D0 publication Critical patent/DK165684D0/da
Publication of DK165684A publication Critical patent/DK165684A/da
Publication of DK163238B publication Critical patent/DK163238B/da
Application granted granted Critical
Publication of DK163238C publication Critical patent/DK163238C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
DK165684A 1983-03-25 1984-03-23 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser DK163238C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/478,965 US4735948A (en) 1983-03-25 1983-03-25 (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
US47896583 1983-03-25

Publications (4)

Publication Number Publication Date
DK165684D0 DK165684D0 (da) 1984-03-23
DK165684A DK165684A (da) 1984-09-26
DK163238B DK163238B (da) 1992-02-10
DK163238C true DK163238C (da) 1992-06-29

Family

ID=23902120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165684A DK163238C (da) 1983-03-25 1984-03-23 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser

Country Status (17)

Country Link
US (1) US4735948A (el)
EP (1) EP0120483B1 (el)
JP (1) JPS59176276A (el)
KR (1) KR900003650B1 (el)
AT (1) ATE26276T1 (el)
AU (1) AU562115B2 (el)
CA (1) CA1241001A (el)
DE (1) DE3462895D1 (el)
DK (1) DK163238C (el)
ES (1) ES8601963A1 (el)
GR (1) GR81908B (el)
IE (1) IE57073B1 (el)
IL (1) IL71319A (el)
NO (1) NO841157L (el)
NZ (1) NZ207581A (el)
PT (1) PT78289B (el)
ZA (1) ZA842065B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
GB9125485D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
EP0670320A4 (en) * 1992-12-01 1997-05-02 Green Cross Corp DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
DE19727410A1 (de) * 1997-06-27 1999-01-07 Hoechst Schering Agrevo Gmbh 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444369A (en) * 1973-04-05 1976-07-28 Allen & Hanburys Ltd 1,8-naphthyridines
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
KR900003650B1 (ko) 1990-05-28
EP0120483B1 (en) 1987-04-01
EP0120483A1 (en) 1984-10-03
ZA842065B (en) 1984-10-31
ES530877A0 (es) 1985-11-01
CA1241001A (en) 1988-08-23
NO841157L (no) 1984-09-26
DK163238B (da) 1992-02-10
DK165684D0 (da) 1984-03-23
KR840008153A (ko) 1984-12-13
JPS59176276A (ja) 1984-10-05
IE840720L (en) 1984-09-25
DK165684A (da) 1984-09-26
ATE26276T1 (de) 1987-04-15
AU562115B2 (en) 1987-05-28
JPH0452273B2 (el) 1992-08-21
IL71319A0 (en) 1984-06-29
DE3462895D1 (de) 1987-05-07
AU2595284A (en) 1984-09-27
PT78289A (en) 1984-04-01
PT78289B (en) 1986-04-22
IL71319A (en) 1988-03-31
ES8601963A1 (es) 1985-11-01
GR81908B (el) 1984-12-12
NZ207581A (en) 1987-01-23
IE57073B1 (en) 1992-04-22
US4735948A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
NL189141C (nl) Vulcaniseerbaar rubbermengsel en werkwijze voor het bereiden daarvan.
DK397387A (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK167187A (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
IT8004812A0 (it) Procedimento per la riduzione di emissione di nox.
NL8402946A (nl) Antidepressieve 1,2,4-triazolon verbindingen; werkwijzen voor het bereiden daarvan; farmaceutische preparaten.
DK163238C (da) 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser
NL7900455A (nl) Nieuwe gesubstitueerde heterocyclische benzamiden, werkwijze voor de bereiding daarvan en toepassing als gedragsbeinvloedende stoffen.
NL187069C (nl) N-acyl 3-(1-amino-3-methylbutyl)-8-hydroxy-3,4-dihydro-isocoumarine verbinding, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
DK514182A (da) Fremgangsmaade til fremstilling af n-substituerede 2-pyridylindoler eller n-oxider eller salte deraf
FI821218L (fi) Oxindolderivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel med neuroanabolisk verkan
ES530876A0 (es) Un procedimiento para preparar (1h-tetrazol-5-il) tetrazolo (1, 5-a) quinolinas
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
NL7805328A (nl) Azacyclylverbindingen en werkwijze voor het bereiden ervan.
FI890173A (fi) Isoxazoler med nootropisk verkan.
DK564284A (da) Pyrazinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
NL7611315A (nl) Kleurontwikkelaar voor de werkwijze voor het kleuren-fotografische ontwikkelen.
DK428483A (da) Fremgangsmaade til fremstilling af trisubstituerede diazaderivater eller farmaceutisk anvendelige salte deraf
DK491383A (da) 5-phenoxybenzoesyrederivater af pentiter, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med herbicid virkning
ATE29256T1 (de) Oxazolyl substituierte diaza-heterozyklische verbindungen.
DK152755C (da) Fremgangsmaade til fremstilling af 3-substituerede tetrahydro-1,2,4-triaziner eller farmaceutisk acceptable salte heraf
NL7713686A (nl) Werkwijze voor het bereiden van een zuur additie- zout van 3-fenoxypyridine.
DK672289A (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed